Professor of Neurology, Harvard Medical School
29th-30th Mar 2022
San Diego, USA
Sheraton San Diego Hotel & Marina
“We are all set to welcome you to the Sheraton San Diego Hotel & Marina at the end of March. You can book your place now, confident that you will enjoy great networking and learning experience that only comes from in-person, face-to-face meetings.”
Steve Hambrook, CEO, Global Engage
The 2022 meeting features numerous presentations on probiotics discovery and product development, as well as prebiotics, diet and nutrition. Alongside a number of case studies on digestive health, metabolic diseases, ageing, skin health and allergy, the conference highlights the developments in personalised nutrition and explores strategies for commercialisation.
New for 2022 are numerous updates on how personalised probiotics and nutrition is delivering a range of health benefits. Plus you have access to the stream exploring probiotics and microbiome for Infant and Women’s health.
A panel will explore the various sources of funding for microbiome products with a further panel on the potential Skin Microbiome research. Expert-led round tables will provide delegates with a forum to discuss a range of topics such as the infant microbiome, manufacturing, funding and the skin microbiome.
“there was a wide spectrum of presentations for Microbiome area, high level of
presenters, especially in Bioinformatics and Computational biology”
“I got to learn about up-to-date research and product development”
“great structure, liked all the talks running in parallel”
Associate Professor, Department of Molecular Biology & Biochemistry and Co-Director, UCI Microbiome Center, University of California, Irvine, USA
Pfizer Research Chair, Co-director of Sentinel North’s Microbiome thematic projects, Department of Medicine, Faculty of Medicine, University of Laval
This programme is designed to create a collaborative environment in which delegates can create enduring relationships across the full range of microbiome and probiotics research.
Principal Scientist, Proctor & Gamble
Principal Scientist, Proctor & Gamble
Published February 2022 (next update 31 March 2022)
It is a condition of entry to the meeting that your have had at least two vaccinations against Covid-19 or that you have had a negative antigen test result taken on 27th or 28th March 2022.
We will require you to complete a declaration confirming your vaccination or test status.
Currently, California recommends the wearing of masks in indoor spaces but is not compulsory. However, the wearing of masks is a personal choice, and all attendees are asked to respect the choices of others.
Masks & hand sanitizer will be available at the registration desk.
The meeting is at the end of March. It will be conducted in accordance with the guidance issued at that time from the CDC, the Sate of California and any relevant San Diego City Ordinances.
This is a meeting of less than 500 people and is not a mega event as defined by the Sate of California
While there has been excellent progress in the vaccine roll-out across the USA and Covid-19 restrictions are being lifted, these regulations are subject to change and review.
We are happy to offer a no quibble refund guarantee should you need to cancel at any time up to and including 28th February 2022.
While there has been excellent progress in the vaccine roll-out across the United States and Covid-19 restrictions are being lifted, these regulations are subject to change and review.
We are happy to offer a no quibble refund guarantee should you need to cancel at any time up to and including 28th February.
3 for the price of 2 offer
5 pass discounted price $500/$1066 per person Academic/Industry
Discount applied automatically when registering places at once. If you do not know all the attendees complete this form
Not applicable for solution provider companies or compatible with any other offers or discount code
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
“You are about to be a part of a great networking meeting. I can’t wait to welcome you in person.”
Steve Hambrook, CEO, Global Engage
Standard registration for those not in the categories below
Entrance Fee for Academic / Non-for-Profit Organisation (USD)
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Poster presentation sessions will take place in breaks and alongside the other breakout sessions of the conference. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.
We also issue a poster eBook to all attendees containing your full abstract, and you can share your poster as a PDF after the meeting if you desire (optional).
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this congress.
In order to present a poster at the forum, you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first-come-first-served basis (subject to checks and successful registration).
POSTER COMPETITION – CLOSING DATE 11th March 2022
At Clinical Microbiomics we offer ‘full-service’ microbiome analysis covering the entire workflow, from extracting DNA from your study samples, over sequencing to profiling and biostatistics, linking the microbiome to clinical outcomes. For us, full-service means supporting you through your study – from planning to the final report. This includes being available throughout your study, during the analysis and for interpretation and discussions of the results. Our clients come from different research areas, including academic institutions, global pharma, nutrition and biotech companies who are developing microbiome-targeted products.
Biose industrie is the worlds leading CDMO for Live Biotherapeutic products – Based in France we have over 30 different LBP programs being run out of our plant with well over a 100 different bacterial strains being developed or manaufactured at GMP level. 2022 will see us double our manufacturing volumes with even bigger expansion plnned in the next 3 years. Come and meet us at the event if you require support for your LBP program.
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies. Our dedicated team, state-of-the-art facilities, and unparalleled expertise are crucial for advancing products from development to commercial launch. Arranta Bio continues to expand capacity and development and manufacturing services across two sites with three distinct technology platforms designed to meet the evolving demands of our clients and partners.
One Trusted Expert, With You on Your Path to the Patient
Microba Life Sciences is a precision microbiome therapeutic company with a research services division empowering life-changing advancements in human health. Microba has built a cutting-edge metagenomics platform around robust sequencing capabilities, leading bio-informatic approaches combined with the most comprehensive genome reference database to turn our and our customer’s discoveries into transformative solutions for medical diagnosis, treatment, and microbiome research.
In addition, through an on-going real-life population study, Microba has built the largest catalogue of human microbiome metagenomes with associated lifestyle and medical metadata that can be mined for microbiome signatures and product discoveries.
Oncodesign is a driver of therapeutic innovation. Its mission is to discover effective therapies for the benefit of patients with cancer and other diseases without a therapeutic solution.
With SOLO-Microbiome service offer, our scientific experts advice you to design the best strategy approach to understand the manipulation and influence of the microbiome. The efficacy of immunotherapies is evaluated in our preclinical in vitro and in vivo proof-of-concept models in oncology, immuno-oncology, inflammation and for COVID-19.
Labskin’s pioneering approach to testing skin care products by cloning a patient’s skin microbiome and transplanting it on to Labskin human skin equivalent allows a wide range of testing that no longer requires invasive procedures on patients. Data from next generation sequencing of the Labskin and skin biome is coupled with AI processes to interpret and direct further development of skincare products in a controlled and efficient manner, reducing development time and costs.
vermicon AG, the microbiology specialist from Munich, Germany, provides innovative technologies, specific microbiological expertise and cultivation-independent methods for the in situ identification, quantification and visualization of microorganisms directly at their site of action. By using FISH (Fluorescence In Situ Hybridization), Flow Cytometry, qPCR, NGS and individually adapted solutions, vermicon provides deeper and holistic understanding of the human microbiome and supports pharmaceutical companies and CDMOs involved in the development and production of microbiome-based therapeutics. The company services are GMP certified and include solutions for all stages of the production chain, from research and development to the final product.
Wacker Biotech is “THE MICROBIAL CDMO” – your partner of choice for process development and commercial manufacturing of biopharmaceuticals (proteins, vaccines, live microbial products, and plasmid DNA) using microbial hosts. WACKER’s integrated service portfolio covers molecular biology, process- and analytical development, as well as GMP manufacturing of biologics for clinical and commercial supply.
Wacker Biotech maintains four GMP-compliant production plants in Amsterdam (The Netherlands), San Diego (US) and in the German cities of Jena and Halle.
As one of the leading venture capital firms in Europe, Seventure manages more than €750m at the end of 2018. Since 1997, Seventure has been investing in innovative businesses with high growth potential in Life Sciences in Europe/US/Canada/Israel and Japan
In Life Sciences, Seventure’s preferred fields are:
• Biotechnology and pharmaceuticals
• Nutrition & foodtech
• Connected & digital health and medtech & Dx
• Industrial biotechnology and cleantech
• blue economy
Diversigen offers fast, reliable microbiome analysis using cutting-edge genomics and informatics to power microbiome discoveries. Leverage Diversigen’s CLIA/CAP-accredited microbiome profiling and bioinformatics services across your entire clinical research project lifecycle×
EzBiome is a microbiome company specialized in precision taxonomy, curated databases, and cutting-edge genomic intelligence. Our mission is to elevate and accelerate the discovery and development of universal microbiome-based disease diagnostics and transformative therapeutics for microbiome-related diseases to revolutionize microbiology and medicine. Through our Bio-Digital platform, we serve the global community to educate, inspire and harness microbiome treasures for the benefit of mankind.
Ardigen is harnessing advanced AI methods for novel precision medicine. The company accelerates therapy development by designing immunity, decoding microbiome, analyzing biomedical images and providing digital drug discovery services. Ardigen’s team is rooted in biology and holds deep expertise in bioinformatics, machine learning, and software engineering. The company’s in-house datasets, together with advanced AI platforms, empower the development of effective precision therapies.
Bacthera is a Danish/Swiss-based one-stop CDMO in the field of LBP’s, with the overall goal to enable the entire industry to further flourish by introducing industry changing innovations.
From small start-up’s to globally operating pharmaceutical companies, we support our clients developing analytical and manufacturing processes of their strains. With our long experience in handling bacteria in DS and DP production, we can offer tailor-made development and large-scale commercial solutions out of our Microbiome Center of Excellence.
Human Metabolome Technologies-America, Inc., (HMT-A) is in Boston, MA. HMT was founded in 2003 by Professor Masaru Tomita, Ph.D., Director of the Institute for Advanced Biosciences (IAB), Keio University, Japan, and by IAB’s Professor Tomoyoshi Soga, Ph.D. HMT is a Japan-based biotechnology company that provides capillary electrophoresis mass spectrometry (CEMS) and liquid-chromatography-mass spectrometry (LCMS) based metabolomics services, aiming to provide targeted and untargeted solutions for metabolomics research.
DNA Genotek Inc. is a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR) working to provide high-quality biological sample collection products and services for human genomics, microbiome and infectious disease applications. DNA Genotek’s OMNIgene products for self-collection of stool, oral, skin, and vaginal samples immediately stabilizes the microbial community at the point of collection, ensuring an unbiased ‘snapshot’.
TargEDys® is a commercial-stage French biotech specialized in the development of breakthrough microbiome-based nutraceutical solutions. The company is the fruit of over 15 years of research within academic laboratories. The team developed and launched a first product based on Hafnia alvei HA4597™ with clinically demonstrated efficacy in weight and appetite. Targedys® portfolio focuses on overweight, undernutrition and mental wellbeing, all based on PreciBiomic strains backed by a molecular mechanism of action and in vivo studies.×
Intralytix, Inc. is a biotechnology company focused on the discovery, production, and marketing of bacteriophage (phage)-based products to control specific bacterial pathogens in environmental, food processing, and medical settings, including oral care and skin care. The company is the largest producer of FDA-approved phage products for food safety applications in the world, with its state-of-the-art R&D and cGMP-compliant production facilities located in Columbia, Maryland.
Microbiology International specializes in equipment that quickly automates tedious, manual lab processes and when combined with our ability to provide customized culture media products, and pathogen ID kits, we are able to make your laboratory as efficient as possible. In short, we offer our clients the total lab solution. Stop by our booth for a demonstration of the Whitley A35 Anaerobic Workstation, this advanced chamber has many features to ensure a strict anaerobic environment.
Anaerobe Systems has over 40 years of experience specializing in manufacturing pre-reduced anaerobic culture media, anaerobic transport media, and anaerobic chambers for the cultivation and transport of anaerobic organisms. We specialize in producing customized media formulations to meet our customer’s unique requirements and have a range of standard products that support the growth of human microbiota. Anaerobe Systems manufactures and sells anaerobic chambers which provide an oxygen free environment for manipulation and growth of anaerobic organisms.
Eurofins “Probiotics Center of Excellence” offers a complete range of contract laboratory testing services from probiotic enumeration to identification and contamination. We actively partner with probiotic raw material suppliers to offer specific enumeration methods that allow Eurofins customers to test with confidence. Whether you’re an ingredient supplier or sell finished products direct to consumers, your bottom line depends on our top-of-the-line services.
Invitek Molecular offers complete solutions for reliable and validated microbiome sample management, from sample collection and stabilization to manual and automated DNA extraction.
With the Stool Collection Tubes, we offer a versatile tool for gut microbiome analysis, microbiome-associated disease research, nutrigenomics and veterinary studies. For oral microbiome studies, we offer several options for saliva and swab samples.
Our collection and extraction systems guarantee excellent performance in downstream NGS applications.
Luina Bio is Australia’s most experienced biopharmaceutical CDMO. We perform process development and GMP manufacture of
• Recombinant proteins
• Bacterial Vaccines
• Live Biotherapeutics
• Plasmid DNA
More specifically Luina Bio carries out microbial aerobic and anaerobic fermentation, technical transfer, cell banking, process development and validation, analytical development, GMP production and stability studies.
• We offer 20 years’ expertise in bacterial/yeast production GMP material for:
Pre-clinical, Clinical Phases 1, 2 & 3
• Highly cost competitive
• Flexible with fast access and turnaround times
With a reputation for innovation, COPAN is the leading manufacturer of collection and transport systems in the world. COPAN’s collaborative approach to innovation in pre-analytics has resulted in the original FLOQSwabs™, ESwab™, FecalSwab™ and UTM™, as well as Full Laboratory Automation. COPAN’s collection and systems have been proven to advance the quality of traditional and contemporary microbiology assays. COPAN’s automation includes specimen processing, smart incubation, digital imaging, and strong algorithms for automatic segregation of bacterial cultures.
Bio-Me is transforming microbiome analysis by making it possible to analyze hundreds of samples in less than a day, with high resolution and reproducibility and at an affordable cost. Combined with an exclusive biobank and extensive patient database, Bio-Me’s Precision Microbiome Profiling platform (PMP™) enables the development of clinical tests that will improve health and well-being worldwide.
Quay Pharma is experienced in formulation development and is one of very few companies licensed to provide clinical manufacturing materials containing live bacterial strains being targeted for delivery to, and in the digestive, urogenital, otorhinologic and pulmonary tracts. Understanding the clients dosing requirements for the live biotherapeutic, Quay can prepare a formulation development strategy to bring your live bacterial strain rapidly and effective to First in Man studies aiming to provide a formulation with the best change of clinical.
RB is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.
RB is proud to have a stable of trusted household brands found in households in more than 190 countries. These include Enfamil, Nutramigen, Mucinex, Dettol, Durex, Lysol, Digestive Advantage, Bodi-Ome, and more.
For more information visit https://www.rb.com/
EpiCor whole food fermentate manufactured by Cargill Health Technologies is a postbiotic ingredient clinically shown to support the immune system and beneficially modulate the gut microbiota. Backed by over 75 years of fermentation expertise, EpiCor is made through a natural proprietary process that creates a unique fingerprint of metabolites. Inspired by a real-life health discovery and supported by clinical research, EpiCor helps people live more healthy days.
LYSANDO AG is the world leader in the development of unique antimicrobial proteins, Artilysin®s, to combat gram-positive and gram-negative bacteria. Our mission is to introduce the Artilysin® Platform Technology as the answer to the increasing threat of antibiotic resistant and persistent bacterial infections. As Artilysin®s are resistant stable, safe for the microbiome and can be tailored towards the customers´ specific requirements, Lysando AG has a solution, suitable for every customer.×
TNO is a research and technology innovation institute with established capabilities and track record in determining relationships between diet or drugs, gut microbiome and host health. With a suite of advanced technologies we offer comprehensive approaches to address our customers’ questions on product functionality and microbiome related health. These technologies and their applications include i-screen, InTESTine TM (ex vivo technologies), organoids and gut-on-a-chip for in depth in vitro studies.
bitBiome provides “microbial single-cell genomic analysis” as a service for various industries/academia researchers, from basic research to product development.
Our proprietary single-cell, whole-genome analytical platform called bit-MAP enables strain-level differentiation and functional analyses with high accuracy, broad spectrum of bacteria, and high throughput.
It delivers unprecedented strain-level genomics with functional insights into microbiome not available with the existing technologies.
Bio-Me is transforming microbiome analysis by making it possible to analyze hundreds of samples in less than a day, with high resolution and reproducibility and at an affordable cost. Combined with an exclusive biobank and extensive patient database, Bio-Me’s Precision Microbiome Profiling platform (PMP™) enables the development of clinical tests that will improve health and well-being worldwide.×
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
For further details please contact
Telephone +44 (0) 1865 849841 or
email [email protected]
Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal. The journal contains original research papers and critical reviews in all areas dealing with beneficial microbes in both the small and large intestine, together with opinions, a calendar of forthcoming beneficial microbes-related events and book reviews. The journal takes a multidisciplinary approach and focuses on a broad spectrum of issues, including safety aspects of pro- & prebiotics, regulatory aspects, mechanisms of action, health benefits for the host, optimal production processes, screening methods, (meta)genomics, proteomics and metabolomics, host and bacterial physiology, application, and role in health and disease in man and animal. Beneficial Microbes is intended to serve the needs of researchers and professionals from the scientific community and industry, as well as those of policymakers and regulators.
Microbiome Research Reports (MRR) is an international peer-reviewed, open access journal. All articles published by MRR are made freely and permanently accessible online immediately from the date of publication.
The scope of the journal includes investigations of microbiomes present in one or various body compartments of human beings or other animals. Surveys on the establishment of microbial communities as well as on microbe-microbe interactions and microbe-host communication will be considered for publication. The overall aim of MRR is to publish high quality researches from scientists with a common interest in microbiome/microbiota research in all its multidisciplinary aspects.×
rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions.
Keep up-to-date with the latest microbiology news by getting our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.